When immune activity reflecting potential response to pembrolizumab in HNSCC tumors was assessed by using IFNG scores, tumors in YA subtype have lower scores and IFNG scores were negatively correlated with YAP1 activity, suggesting that YAP1 may be involved in regulation of host immunity against cancer cells. This evidence concerns the gene YAP1 and head and neck squamous cell carcinoma.